Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Cramer
S F
SF
D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D005260:Female; D005355:Fibrosis / Q000473:pathology; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists*; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy / Q000473:pathology*; D016729:Leuprolide / Q000627:therapeutic use*; D008593:Menopause; D008875:Middle Aged; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology*
D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D016729:Leuprolide